Dispensing Solution

Drug Quality Dispensing Part 1

Drug-Quality-Dispensing-Part-1When considering dispensing medications from their offices, physicians often ask about the origin of the pharmaceuticals we distribute. What they are really asking is “how do I know that you are selling safe and effective pharmaceuticals?”  

The first source to validate pharmaceuticals is the FDA.  Their Orange Book is essentially a list of all pharmaceuticals evaluated by the FDA for safety and effectiveness.  For generics, the products should be rated AA, AB, AN, AO, AP or AT.  This indicates that they are considered therapeutically equivalent to the original brand product.

What is therapeutic equivalence?

  1. They are approved as safe and effective
  2. They are pharmaceutical equivalents in that they

(a) Contain identical amounts of the same active drug ingredient in the same dosage form and route of administration

(b) Meet compendia or other applicable standards of strength, quality, purity, and identity

  1. They are bioequivalent in that

(a) They do not present a known or potential bioequivalence problem and they meet an acceptable in vitro standard

(b) If they do present such a known or potential problem, they are shown to meet an appropriate bioequivalence standard

  1. They are adequately labeled
  2. They are manufactured in compliance with Current Good Manufacturing Practice regulations.

Northwind Pharmaceuticals only distributes products rated in the Orange Book in the categories above.  When you partner with us, you can be sure you are getting the best, both in products and in service.Contact us today to learn how our solutions can work for you.

Schedule a free claims analysis now.

Let’s Talk now

Podcast: Northwind’s Member Focused Approach

Phillip Berry | Sep 25th, 2024
Click here to listen to Katherine Lurke, PharmD and Steve Zetzl, PharmD discuss Northwind’s member focused approach to pharmacy benefit management. Unlike traditional PBM models like you are used to hearing about, Northwind’s PSA (Phamacy Administration Services) prioritizes continuous patient engagement. Steve and Katherine break down how their team works to ensure that once medications are in … more »

continue reading

We’re All in the Business of Healthcare

Phillip Berry | Aug 14th, 2024
Employers and unions have begun to realize that they are very much in the business of healthcare and that they are the “payer.” The move toward self-funding continues to build momentum as costs increase and employers discover that the healthcare universe revolves around a few massive payers. American healthcare has become a $4.5 trillion galaxy … more »

continue reading

The PBM Conflagration Marks the Beginning of Healthcare’s Center-of-Gravity Shift

Phillip Berry | Jul 31st, 2024
Waiting for my turn to present at recent health system executive conference, I noticed that presentations before mine spent a significant amount of time lamenting “payers” and “reimbursements.” Strategies and solutions to address these challenges centered on cutting costs, pooling resources to increase negotiating leverage, lobbying, and aligning with larger health systems to bolster positioning. … more »

continue reading